According to VaccineNewsDaily.com, “Bavarian Nordic recently became part of a joint collaboration involving the Technical University of Denmark (DTU) and Evaxion Biotech — a Danish biotechnology company — to develop a vaccine for Methicillin-resistant Staphylococcus aureus (MRSA).”